Popular on EntSun
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com - 243
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 221
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures - 216
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 207
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV - 157
- Token-Operated Sake Service Opens at Tobu Nikko Station - 134
- Honoring Black History, Culture, and Community in Fall River - 131
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research - 125
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits - 117
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) - 111
Similar on EntSun
- The Blue Luna Encourages Local Schools to Take Steps to Enhance Safety for Students and Staff
- Smart Resnse Unveils Smart Resnse(SRMS) Token-Powered AI Orchestration Platform to Revolutionize Multi-Billion Dollar Market
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
Braeden William Lichti: Healthcare Investing in 2021
EntSun News/10862849
VANCOUVER, British Columbia - EntSun -- Tech and healthcare are working together in the COVID-19 pandemic to benefit the greater good. That's why CNBC has predicted that both industries, including biopharma and biotech, will make gains in 2021. COVID-19 has put biopharma in the limelight and big-name tech investors are moving in: for example, tech entrepreneur and Facebook co-founder Peter Thiel recently joined a $35.4 million Series B round for Peptilogics.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on EntSun News
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on EntSun News
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on EntSun News
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
- The Battle for the Enchanted Forest Brings Fantasy, Fun, and Fundraising!
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on EntSun News
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- Colbert Packaging Announces WBENC Recognition
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Bay Street Yard to host "Love Island" finale watch party July 13
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Source: Braeden William Sinclair Lichti
0 Comments
Latest on EntSun News
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- American Made Ivey Abitz Bespoke Clothing Travels for Summer
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- Bruce In The USA Brings Immersive Bruce Springsteen Celebration to Frederick This October
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Mental: Elderly Abuse a Documentary
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Rising to New Heights in the Mile High City with Destination: Scientology, Denver
- The City's Largest and Most Elegant Dinner Party Returns on September 13, 2025
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Voting Opens Tonight for the 2025 Spin Awards Honoring Excellence in Christian Gospel Radio
- Introducing LK Blue: The Cool-Girl Denim Brand That's Redefining LA Style Launches E-Commerce
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest